<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://rakovina.dreamhosters.com/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-closing-of-first-tranche-upsize-and-extension-of-non-brokered-private-placement/</loc><lastmod>2026-08-14T05:06:41+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-1-5-million-private-placement/</loc><lastmod>2026-08-14T17:36:58+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-q1-2026-financial-results-and-provides-corporate-update/</loc><lastmod>2026-08-14T05:27:57+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-debentureholder-election-to-receive-shares-in-partial-satisfaction-of-debenture-interest-payment-obligations/</loc><lastmod>2024-05-24T20:32:06+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-1-5-million-non-brokered-private-placement/</loc><lastmod>2024-05-24T03:05:36+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-2024-q1-financial-results-and-provides-corporate-update/</loc><lastmod>2024-05-31T04:41:21+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-oversubscribed-private-placement-and-results-from-2024-annual-general-meeting/</loc><lastmod>2024-06-20T21:45:09+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-second-upsizing-of-private-placement/</loc><lastmod>2024-07-23T16:22:07+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-provides-update-on-previously-announced-private-placement/</loc><lastmod>2024-07-23T16:27:56+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-closes-previously-announced-over-subscribed-private-placement/</loc><lastmod>2024-07-27T01:57:58+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-2024-q2-financial-results-and-provides-corporate-update/</loc><lastmod>2024-08-30T20:36:46+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-and-variational-ai-announce-drug-discovery-collaboration/</loc><lastmod>2024-09-17T05:30:00+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-initial-drug-candidates-from-deep-docking-ai-molecule-discovery-platform/</loc><lastmod>2024-10-23T04:30:00+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-to-present-research-highlighting-small-molecule-bifunctional-inhibitors-of-parp1-2-and-hdac-enzymes-at-the-36th-eortc-nci-aacr-symposium-in-barcelona-spain/</loc><lastmod>2024-10-25T10:20:06+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-upcoming-poster-presentation-at-the-29th-annual-society-for-neuro-oncology-meeting-in-houston-texas/</loc><lastmod>2024-11-20T21:48:29+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-presents-ai-driven-drug-discovery-research-at-society-for-neuro-oncology-annual-meeting/</loc><lastmod>2024-11-25T15:41:11+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-private-placement-offering/</loc><lastmod>2024-11-28T07:46:29+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-increase-in-private-placement-offering-to-2-5-million/</loc><lastmod>2024-11-29T03:57:21+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-2024-q3-financial-results-and-provides-corporate-update/</loc><lastmod>2024-12-02T18:07:24+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-presentation-at-the-13th-annual-tumour-models-london-summit/</loc><lastmod>2024-12-03T18:03:10+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-increases-private-placement-offering-to-3-0-million/</loc><lastmod>2024-12-03T18:10:16+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-closing-of-oversubscribed-3m-private-placement/</loc><lastmod>2024-12-15T23:41:11+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-announces-debentureholder-election-to-receive-shares-in-partial-satisfaction-of-debenture-interest-payment-obligations/</loc><lastmod>2024-12-19T00:08:24+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/reflecting-on-2024-success-and-building-momentum-for-a-transformative-2025/</loc><lastmod>2024-12-19T13:30:01+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-to-connect-with-industry-leaders-during-43rd-annual-j-p-morgan-healthcare-conference-week/</loc><lastmod>2025-01-03T23:00:34+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-receipt-of-ai-derived-drug-candidates-and-advancement-to-preclinical-validation/</loc><lastmod>2025-01-06T14:18:00+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-key-milestone-in-cancer-drug-innovation-in-collaboration-with-variational-ai/</loc><lastmod>2025-01-13T13:48:09+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-comments-on-500-billion-ai-infrastructure-investment-and-its-implications-for-healthcare-innovation/</loc><lastmod>2025-01-22T12:30:02+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-to-participate-in-bioinnovate-ubc-annual-conference/</loc><lastmod>2025-01-29T14:09:12+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-listing-on-frankfurt-stock-exchange/</loc><lastmod>2025-01-31T15:34:41+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-additional-synthesized-compounds-in-its-ai-driven-cancer-drug-discovery-program/</loc><lastmod>2025-02-06T13:02:57+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-and-variational-ai-strengthen-partnership/</loc><lastmod>2025-02-26T16:07:18+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/next-gen-cancer-treatment-rakovinas-ai-driven-atr-inhibitors-enter-preclinical-testing/</loc><lastmod>2025-03-12T11:46:05+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-unveils-preclinical-data-at-the-aacr-worlds-premier-cancer-research-forum/</loc><lastmod>2025-03-27T11:20:32+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-congratulates-scientific-advisor-dr-artem-cherkasov-on-global-recognition-for-breakthrough-ai-innovation-in-drug-discovery/</loc><lastmod>2025-04-22T08:30:00+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-showcases-preclinical-results-of-novel-ai-discovered-cancer-therapies-at-aacr-2025/</loc><lastmod>2025-04-29T21:15:48+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-strengthens-board-with-appointments-of-yevgeniy-meshcherekov-and-david-kideckel/</loc><lastmod>2025-04-29T08:30:00+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-inc-announces-2024-financial-results-and-provides-corporate-update/</loc><lastmod>2025-04-30T16:39:16+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-strategic-private-placement-convertible-debt-financing-and-share-consolidation-to-accelerate-us-focused-growth-and-ai-powered-oncology-innovation-2/</loc><lastmod>2025-05-15T08:00:00+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-appointment-of-dr-david-kideckel-aschief-financial-officer/</loc><lastmod>2025-05-05T08:00:00+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-appointment-of-dr-david-kideckel-as-chief-financial-officer/</loc><lastmod>2025-05-30T16:40:07+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-announces-debentureholder-election-to-receive-shares-in-partial-satisfaction-of-debenture-interest-payment-obligations-2/</loc><lastmod>2025-05-28T08:00:00+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-2025-q1-financial-results-and-providescorporate-update/</loc><lastmod>2025-06-02T08:00:00+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rkv-close-of-private-placement-06062025/</loc><lastmod>2025-06-20T21:00:13+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-to-attend-bio-international-convention-to-advance-strategic-partnering-opportunities/</loc><lastmod>2025-06-20T21:07:06+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-share-consolidation-effective-date/</loc><lastmod>2025-06-20T21:11:26+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-results-from-2025-annual-general-meeting/</loc><lastmod>2025-06-26T07:32:56+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-intention-to-amend-debentures-and-warrants/</loc><lastmod>2025-07-01T16:38:08+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-highlights-strong-h1-progress-and-unveils-strategic-priorities-for-h2-2025/</loc><lastmod>2025-07-01T16:40:23+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-highlights-strength-of-scientific-advisory-board/</loc><lastmod>2025-07-10T21:25:31+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-congratulates-partner-variational-al/</loc><lastmod>2025-07-11T18:28:12+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-granted-dtc-eligibility-to-expand-u-s-investor-access/</loc><lastmod>2025-07-15T16:50:07+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-kt-5000al-program-yields-potent-atr-inhibitor-hits-in-early-screening/</loc><lastmod>2025-07-24T06:40:12+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-highlights-long-standing-collaboration-with-the-university-of-british-columbia-and-the-vancouver-prostate-centre/</loc><lastmod>2025-08-01T00:26:49+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-and-nanopalm-ltd-sign-letter-of-intent-to-form-joint-venture-leveraging-al-discovered-oncology-therapies-and-novel-lipid-nanoparticle-delivery-technologies/</loc><lastmod>2025-08-13T16:04:24+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-warrant-exercise-incentive-program/</loc><lastmod>2025-08-21T23:41:48+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-cso-dr-mads-daugaard-invited-to-present-at-the-13th-tuscany-retreat-on-cancer-research-and-apoptosis/</loc><lastmod>2025-08-26T16:48:05+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-stock-option-grants/</loc><lastmod>2025-08-29T16:20:04+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-three-month-q2-ended-june-30-2025-financial-results-and-provides-corporate-update/</loc><lastmod>2025-08-29T16:28:20+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference/</loc><lastmod>2025-09-17T17:43:09+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference-2/</loc><lastmod>2025-10-07T17:06:42+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-to-present-new-data-highlighting-novel-atr-inhibitor-with-cns-penetration-at-the-aacr-nci-eortc-international-conference/</loc><lastmod>2025-10-16T12:42:36+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-showcases-potent-ai-developed-atr-inhibitors-with-cns-penetrance-at-aacr-nci-eortc-international-conference/</loc><lastmod>2025-10-27T12:31:47+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-to-present-new-data-highlighting-cns-penetrant-atr-and-parp1-inhibitors-at-the-2025-society-for-neuro-oncology-annual-meeting/</loc><lastmod>2025-11-10T17:56:29+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-president-cso-to-present-and-join-expert-panel-at-the-9th-annual-ddr-inhibitors-summit/</loc><lastmod>2025-11-18T15:22:30+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-showcases-compelling-preclinical-data-on-ai-discovered-cns-penetrant-atr-mtor-inhibitors-at-the-2025-society-for-neuro-oncology-annual-meeting/</loc><lastmod>2025-11-24T13:30:21+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-inc-announces-presentation-of-second-abstract-at-the-2025-society-for-neuro-oncology-annual-meeting/</loc><lastmod>2025-11-24T13:47:16+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-debentureholder-approval-of-debenture-extension-expiry-of-warrant-incentive-program/</loc><lastmod>2025-12-02T06:25:38+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-three-month-q3-ended-september-30-2025-financial-results-and-provides-corporate-update/</loc><lastmod>2025-12-02T06:28:43+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-upcoming-webinar-with-variational-ai/</loc><lastmod>2025-12-16T13:39:03+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-management-to-attend-partnering-meetings-during-jpm-week-january-in-san-francisco-california/</loc><lastmod>2025-12-22T04:02:15+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-and-variational-ai-expand-collaboration-to-advance-next-generation-atr-inhibitors/</loc><lastmod>2026-01-08T14:33:40+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-corporate-update-including-up-to-1-6-million-in-new-financing-leadership-appointments-and-debt-restructuring/</loc><lastmod>2026-01-28T03:36:01+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-reports-strong-industry-validation-and-emerging-collaborations-following-9th-annual-ddr-inhibitors-summit/</loc><lastmod>2026-02-04T13:25:33+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-upsized-financing-up-to-2-0-million/</loc><lastmod>2026-02-23T13:37:01+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-announces-closing-of-1-million-debenture-unit-private-placement-and-debt-settlement-agreements/</loc><lastmod>2026-03-10T16:20:33+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-extension-of-non-brokered-private-placement/</loc><lastmod>2026-03-12T20:17:35+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-to-present-new-data-at-the-aacr-annual-meeting-2026-worlds-premier-cancer-research-forum/</loc><lastmod>2026-03-23T12:52:45+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-presents-new-preclinical-data-at-aacr-2026-annual-meeting/</loc><lastmod>2026-04-22T13:13:19+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-inc-announces-2025-financial-results-and-provides-corporate-update/</loc><lastmod>2026-04-30T21:44:15+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-q1-2026-financial-results-and-provides-corporate-update-2/</loc><lastmod>2026-06-03T13:29:47+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-1-5-million-private-placement-2/</loc><lastmod>2026-07-16T21:03:31+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-closing-of-first-tranche-upsize-and-extension-of-non-brokered-private-placement-2/</loc><lastmod>2026-08-12T21:41:46+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-results-from-2026-annual-general-meeting/</loc><lastmod>2026-08-31T13:03:26+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-appointment-of-professor-petra-hamerlik-to-its-board-of-directors/</loc><lastmod>2026-09-10T16:58:27+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-final-closing-of-upsized-non-brokered-private-placement/</loc><lastmod>2026-08-31T17:09:51+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-announces-appointment-of-new-scientific-advisory-board-member/</loc><lastmod>2026-09-18T17:59:35+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-partners-with-boston-based-celvion-therapeutics-to-leverage-ai-and-real-world-clinical-data-for-precision-cancer-drug-development/</loc><lastmod>2026-10-01T15:13:29+00:00</lastmod></url><url><loc>https://rakovina.dreamhosters.com/rakovina-therapeutics-secures-exclusivity-on-optimized-kt-5000-lead-profile-from-variational-ai/</loc><lastmod>2026-10-14T16:52:49+00:00</lastmod></url></urlset>
